Page last updated: 2024-10-20

pteridines and Body Weight

pteridines has been researched along with Body Weight in 7 studies

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"In treated tumors, cells arrest in prometaphase, accumulate phosphohistone H3, and contain aberrant mitotic spindles."1.34BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. ( Adolf, GR; Baum, A; Garin-Chesa, P; Grauert, M; Gürtler, U; Hoffmann, M; Kraut, N; Krssák, M; Lénárt, P; Lieb, S; Peters, JM; Petronczki, M; Quant, J; Rettig, WJ; Steegmaier, M, 2007)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RUBEGNI, M1
RAVENNI, G1
FORCONI, S1
Steegmaier, M1
Hoffmann, M1
Baum, A1
Lénárt, P1
Petronczki, M1
Krssák, M1
Gürtler, U1
Garin-Chesa, P1
Lieb, S1
Quant, J1
Grauert, M1
Adolf, GR1
Kraut, N1
Peters, JM1
Rettig, WJ1
Yoshida, YI1
Eda, S1
Masada, M1
McIntosh, MJ1
Meredith, PA1
Moore, MR1
Goldberg, A1
Simmonds, HA1
Hatfield, PJ1
Cameron, JS1
Jones, AS1
Cadenhead, A1
Quoidbach, A1
Busset, R1
Jenny, M2

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1 Dose Escalation Study of Hepatic Intra-Arterial Administration of TKM 080301 (Lipid Nanoparticles Containing siRNA Against the PLK1 Gene Product) in Patients With Colorectal, Pancreas, Gastric, Breast, Ovarian and Esophageal Cancers With Hepatic[NCT01437007]Phase 11 participants (Actual)Interventional2011-08-26Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

7 other studies available for pteridines and Body Weight

ArticleYear
[ON THE MECHANISM OF ACTION OF THE DIURETIC ACTIVITY OF 2,4,7-TRIAMINO-6-PHENYL-PTERIDINE (TRIAMTERENE)].
    Minerva medica, 1963, Sep-19, Volume: 54

    Topics: Aldosterone; Ascites; Blood Chemical Analysis; Body Weight; Diuretics; Heart Failure; Humans; Hypera

1963
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.
    Current biology : CB, 2007, Feb-20, Volume: 17, Issue:4

    Topics: Animals; Apoptosis; Body Weight; Cell Cycle; Cell Cycle Proteins; Dose-Response Relationship, Drug;

2007
Alterations of tetrahydrobiopterin biosynthesis and pteridine levels in mouse tissues during growth and aging.
    Brain & development, 2000, Volume: 22 Suppl 1

    Topics: Aging; Animals; Animals, Newborn; Biopterins; Body Weight; Brain; Growth; Kidney; Liver; Mice; Mice,

2000
Neurotoxic action of lead: effect on tetrahydrobiopterin metabolism in the rat.
    Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1985, Volume: 81, Issue:1

    Topics: Animals; Biopterins; Body Weight; Bone and Bones; Brain; Dihydropteridine Reductase; Lead; Lead Pois

1985
Metabolic studies of purine metabolism in the pig during the oral administration of guanine and allopurinol.
    Biochemical pharmacology, 1973, Oct-15, Volume: 22, Issue:20

    Topics: Administration, Oral; Allopurinol; Animals; Appetite; Body Weight; Carbon Radioisotopes; Castration;

1973
[Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Praxis, 1969, Sep-23, Volume: 58, Issue:38

    Topics: Aged; Ascites; Body Composition; Body Weight; Chlorides; Diuretics; Edema; Female; Humans; Liver Cir

1969
[Study of the new diuretic: Amiloride (MK-870)].
    Praxis, 1969, Sep-23, Volume: 58, Issue:38

    Topics: Aged; Ascites; Body Weight; Diuresis; Diuretics; Edema; Female; Heart Failure; Humans; Liver Cirrhos

1969